Lillington, D M <br/><br/>
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 2001 
 - 2472-81 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.9.2472  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Chromosome Aberrations<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myeloid, Acute--chemically induced<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Myelodysplastic Syndromes--chemically induced<br/>Neoplasms, Second Primary--chemically induced